Treatment of limited small cell lung cancer: An old or new challenge?

Current Opinion in Oncology

Volumn 23, Issue 2, 2011, Pages 158-162

  Blackhall, Fiona ^a   Faivre Finn, Corinne ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

chemotherapy; radiotherapy; review; small cell lung cancer; targeted agents

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IRINOTECAN; PACLITAXEL; PLATINUM DERIVATIVE; TIRAPAZAMINE;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; SMALL CELL LUNG CARCINOMA;

EID: 79952005627     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328341ee4d     Document Type: Article

References (43)

1. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of smallcell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24:4539-4544. (Pubitemid 46630948)
2. Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340:265-271. (Pubitemid 29063268)
3. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3 1973; 4:31-42.
4. Stahel R, Ginsberg RJ, Havemann K. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989; 5:119-126. (Pubitemid 20053516)
5. Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007; 2:1067-1077. (Pubitemid 350307898)
6. Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4:1049-1059.
7. Brink I, Schumacher T, Mix M, et al. Impact of [18F] FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004; 31:1614-1620. (Pubitemid 40104607)
8. Bradley JD, Dehdashti F, Mintun MA, et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004; 22:3248-3254. (Pubitemid 41103679)
9. Niho S, Fujii H, Murakami K, et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer. Lung Cancer 2007; 57:328-333. (Pubitemid 47285426)
10. Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 1973; 2:63-65.
11. Sierocki JS, Hilaris BS, Hopfan S, et al. cis- Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 1979; 63:1593-1597. (Pubitemid 10167762)
12. Einhorn LH, Fee WH, Farber MO, et al. Improved chemotherapy for small-cell undifferentiated lung cancer. JAMA 1976; 235:1225-1229.
13. Medical Research Council Lung Cancer Working Party. Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Br J Cancer 1979; 40:1-10.
14. Bergsagel DE, Jenkin RD, Pringle JF, et al. Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Cancer 1972; 30:621-627.
15. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327:1618-1624.
16. Catane R, Lichter A, Lee YJ, et al. Small cell lung cancer: analysis of treatment factors contributing to prolonged survival. Cancer 1981; 48:1936-1943. (Pubitemid 12231542)
17. McCracken JD, Janaki LM, Crowley JJ, et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J Clin Oncol 1990; 8:892-898. (Pubitemid 20148283)
18. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002; 20:3054-3060. (Pubitemid 34791094)
19. Lorigan P, Woll PJ, O'BrienME, et al. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in betterprognosis small-cell lung cancer. J Natl Cancer Inst 2005; 97:666-674. (Pubitemid 40812630)
20. Rossi A, Garassino MC, Cinquini M, et al. Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis. Lung Cancer 2010; 70:119-128.
21. Lim E, Belcher E, Yap YK, et al. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008; 3:1267-1271.
22. Schreiber D, Rineer J, Weedon J, et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? Cancer 2010; 6:1350-1357.
23. Jiang J, Liang X, Zhou X, et al. A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2010; 5:867-873.
24. Ettinger DS. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer. Semin Radiat Oncol 1999; .9. (2 Suppl 1):148-150. (Pubitemid 29190425)
25. Bremnes RM, Sundstrom S, Vilsvik J, Aasebo U. Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer. J Clin Oncol 2001; 19:3532-3538. (Pubitemid 32737199)
26. Baas P, Belderbos JS, Senan S, et al. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study. Br J Cancer 2006; 94:625-630. (Pubitemid 43361891)
27. Xenidis N, Kotsakis A, Kalykaki A, et al. Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: a multicenter phase II study. Lung Cancer 2010; 68:450-454.
28. Langer CJ, Somer R, Litwin S, et al. Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced nonsmall cell lung carcinoma. J Thorac Oncol 2007; 2:203-209. (Pubitemid 47181325)
29. Ettinger DS, Jotte R, Lorigan P, et al. Phase II study of amrubicin as secondline therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol 2010; 28:2598-2603.
30. Spigel DR, Hainsworth JD, Yardley DA, et al. Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab. J Clin Oncol 2010; 28:43-48.
31. Le QT, Moon J, Redman M, et al. Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. J Clin Oncol 2009; 27:3014-3019.
32. Blackhall FH, Shepherd FA. Small cell lung cancer and targeted therapies. Curr Opin Oncol 2007; 19:103-108. (Pubitemid 46204348)
33. De Ruysscher D, Bremer RH, Koppe F, et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiother Oncol 2006; 80:307-312. (Pubitemid 44397204)
34. Van Loon J, De Ruysscher D, Wanders R, et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010; 77:329-336.
35. Faivre-Finn C, Blackhall F, Snee M, et al. Improving survival with thoracic radiotherapy in patients with small cell lung cancer. The CONVERT and the REST Trials. Clin Oncol (R Coll Radiol) 2010; 22:547-549.
36. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341:476-484. (Pubitemid 29372887)
37. Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higherdose prophylactic cranial irradiation (PCI) in patients with limitedstage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009; 10:467-474.
38. Le Pechoux C, Laplanche A, Faivre Finn C, et al. Neuro-cognitive follow-up among patients with limited small cell cancer (SCLC) treated with two different doses of prophylactic cranial irradiation (PCI) according to the intergroup phase III trial (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212). J Thorac Oncol 2009; 4:S393.
39. Bayman NA, Sheikh H, Kularatne B, et al. Radiotherapy for small-cell lung cancer: where are we heading? Lung Cancer 2009; 63:307-314.
40. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006; 24:1057-1063. (Pubitemid 46638802)
41. Abidin AZ, Garassino MC, Califano R, et al. Targeted therapies in small cell lung cancer: a review. Ther Adv Med Oncol 2010; 2:25-37.
42. Hou JM, Greystoke A, Lancashire L, et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 2009; 175:808-816.
43. Law AB, Erridge SC,MacKean MJ, et al. Improving outcomes for limited stage small cell lung cancer patients in Scotland with concomitant chemoradiation. Clin Oncol (R Coll Radiol) 2007; 19:188-193.